Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 23
2016 1
2017 6
2018 5
2019 5
2020 1
2021 9
2022 2
2023 9
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 37782740

40 results

Results by year

Filters applied: . Clear all
Page 1
Capmatinib.
[No authors listed] [No authors listed] 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 37782740 Free Books & Documents. Review.
Tepotinib.
[No authors listed] [No authors listed] 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 37782745 Free Books & Documents. Review.
Capmatinib for the treatment of non-small cell lung cancer.
Vansteenkiste JF, Van De Kerkhove C, Wauters E, Van Mol P. Vansteenkiste JF, et al. Expert Rev Anticancer Ther. 2019 Aug;19(8):659-671. doi: 10.1080/14737140.2019.1643239. Epub 2019 Aug 1. Expert Rev Anticancer Ther. 2019. PMID: 31368815 Free article. Review.
Capmatinib: First Approval.
Dhillon S. Dhillon S. Drugs. 2020 Jul;80(11):1125-1131. doi: 10.1007/s40265-020-01347-3. Drugs. 2020. PMID: 32557339 Review.
Capmatinib for non-small cell lung cancer.
Alzofon N, Jimeno A. Alzofon N, et al. Drugs Today (Barc). 2021 Jan;57(1):17-25. doi: 10.1358/dot.2021.57.1.3239638. Drugs Today (Barc). 2021. PMID: 33594387 Review.
Osimertinib.
[No authors listed] [No authors listed] 2017 Jun 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jun 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643814 Free Books & Documents. Review.
40 results